SCHEMBL3401418

SCHEMBL3401418

C[C@@H](O)CCCCO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL41064 1.00
SCHEMBL397922 1.00
1,6-Hexanediol SCHEMBL15347446 0.97 LMNA (0.43)
1,3-Propanediol SCHEMBL21406841 0.97 TDP1 (0.42)
SCHEMBL424124 0.97
SCHEMBL10406986 0.97 LMNA (0.43)
SCHEMBL830579 0.97 LMNA (0.43)
SCHEMBL19411359 0.97 LMNA (0.43)
SCHEMBL554360 0.97 LMNA (0.43)
SCHEMBL13202549 0.97 LMNA (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10676422-B2 Kinetic resolution of racemic hydroxy ester via asymmetric catalytic hydrogenation and application thereof ZHEJIANG JIUZHOU PHARMACEUTICAL CO., LTD. (CN) 2020-06-09 US disclosed
US-20170334831-A1 Kinetic resolution of racemic hydroxy ester via asymmetric catalytic hydrogenation and application thereof ZHEJIANG JIUZHOU PHARMACEUTICAL CO., LTD. (CN) 2017-11-23 US disclosed
US-20170334831-A1 Kinetic resolution of racemic hydroxy ester via asymmetric catalytic hydrogenation and application thereof ZHEJIANG JIUZHOU PHARMACEUTICAL CO., LTD. (CN) 2017-11-23 US disclosed
US-9809566-B2 Organocatalytic process for asymmetric synthesis of decanolides COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2017-11-07 US disclosed
EP-3225614-A1 KINETIC RESOLUTION OF ASYMMETRIC CATALYTIC HYDROGENATION OF RACEMIC -HYDROXY ESTER AND APPLICATION THEREOF Zhejiang Jiuzhou Pharmaceutical Co., Ltd. (CN) 2017-10-04 EP disclosed
US-20100311800-A1 ANGIOTENSIN II RECEPTOR ANTAGONISTS NICOX S.A. (FR) 2010-12-09 US disclosed
EP-2250158-A2 ANGIOTENSIN II RECEPTOR ANTAGONISTS Nicox S.A. (FR) 2010-11-17 EP disclosed
WO-2009106470-A2 ANGIOTENSIN II RECEPTOR ANTAGONISTS NICOX S.A. (FR) 2009-09-03 WO disclosed
US-20090137597-A1 Novel quinoxalinone derivatives MSD K.K. (JP) 2009-05-28 US disclosed
US-7388010-B2 Quinoxalinone derivatives BANYU PHARMACEUTICAL CO., LTD. (JP) 2008-06-17 US disclosed
US-20060019959-A1 Novel quinoxalinone derivatives BANYU PHARMACEUTICAL CO., LTD. TSUKUBA RESEARCH INSTITUTE (JP) 2006-01-26 US disclosed
EP-1557418-A1 NOVEL QUINOXALINE DERIVATIVES BANYU PHARMACEUTICAL CO., LTD. (JP) 2005-07-27 EP disclosed